HLB Therapeutics Co.,Ltd. (KOSDAQ:115450)
South Korea · Delayed Price · Currency is KRW 1,712.00
-142.00 (-7.66%)
Jul 20, 2026, 3:30 PM KST
HLB Therapeutics Market Cap
HLB Therapeutics has a market cap or net worth of 158.48 billion as of July 20, 2026. Its market cap has decreased by -54.08% in one year.
Market Cap
158.48B
Enterprise Value
204.24B
Revenue
67.56B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,712.00
ChartMarket Cap Chart
Since March 26, 2010, HLB Therapeutics's market cap has increased from 105.80B to 158.48B, an increase of 49.78%. That is a compound annual growth rate of 2.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 158.48B | -37.08% |
| Dec 30, 2025 | 251.87B | -73.05% |
| Dec 30, 2024 | 934.49B | 182.02% |
| Dec 28, 2023 | 331.36B | -9.25% |
| Dec 29, 2022 | 365.14B | -3.64% |
| Dec 30, 2021 | 378.91B | -51.22% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Proteina | 265.95B |
| BINEX | 214.65B |
| EASY BIO,Inc. | 208.09B |
| GC Cell | 200.46B |
| Anterogen.Co.,Ltd. | 183.21B |
| JETEMA, | 165.93B |
| Helixmith | 160.93B |
| Bioneer | 160.02B |